#NephMadness 2022: The Year That Cardiology and Nephrology Are Friends
Submit your picks! | NephMadness 2022 | #NephMadness | #Cardiorenal Erin Michos @ErinMichos Erin Michos is an Associate Professor in the Division
Submit your picks! | NephMadness 2022 | #NephMadness | #Cardiorenal Erin Michos @ErinMichos Erin Michos is an Associate Professor in the Division
Sodium/glucose cotransporter 2 inhibitors (SGLT2i / gliflozins) are a novel class of medications which act by inhibiting the SGLT2 transporter
There has been significant interest in SGLT2 inhibitors (SGLT2i) as novel oral anti-hyperglycemic agents that have been recently approved for the
For the first time, an oral add-on treatment, Dapagliflozin (aka Forxiga from Astra Zeneca) has received regulatory approval for managing type 1
For the first time, an oral add-on treatment, Dapagliflozin (aka Forxiga from Astra Zeneca) has received regulatory approval for managing type 1
Dr Abby Spencer joins for highlights and random pearls Summary Recap of random pearls and highlights from SGIM19 Day 1 including: Kidney stone